A Phase 2, Double-blind, Randomized, Placebo-controlled Milticenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus

Administered By

Awarded By

Contributors

Start/End

  • January 1, 2017 - October 31, 2019